Title:
ＢＴＫ阻害薬としての一級カルボキサミド類
Document Type and Number:
Japanese Patent JP6770127
Kind Code:
B2
Abstract:
The invention provides compounds of Formula (I)pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
Inventors:
Dominique Bonafu
Heather M. Davis
Christine E. Frank
Michael M. Friedman
Martin Herold Jr.
Michael Zet Heemann
Raymond Huntley
Augustine Osma
George Shepherd
Gagan Deep Kay Somal
Jennifer Van Camp
Stacy A Van Eps
Anil Busdevan
Greer A Wallace
Lou One
Lou One
Gee One
Noel S. Wilson
Xian Dong Shiu
Heather M. Davis
Christine E. Frank
Michael M. Friedman
Martin Herold Jr.
Michael Zet Heemann
Raymond Huntley
Augustine Osma
George Shepherd
Gagan Deep Kay Somal
Jennifer Van Camp
Stacy A Van Eps
Anil Busdevan
Greer A Wallace
Lou One
Lou One
Gee One
Noel S. Wilson
Xian Dong Shiu
Application Number:
JP2019070362A
Publication Date:
October 14, 2020
Filing Date:
April 02, 2019
Export Citation:
Assignee:
AbbVie Incorporated
International Classes:
C07D413/04; A61K31/404; A61K31/4155; A61K31/422; A61K31/427; A61K31/428; A61K31/436; A61K31/437; A61K31/4439; A61K31/4545; A61K31/4725; A61K31/496; A61K31/506; A61K31/517; A61K31/5377; A61K31/538; A61K31/5383; A61K31/553; A61P1/04; A61P1/06; A61P13/10; A61P13/12; A61P17/06; A61P19/00; A61P19/02; A61P25/00; A61P29/00; A61P35/00; A61P35/02; A61P37/00; A61P37/02; C07D209/14; C07D209/18; C07D401/04; C07D401/14; C07D403/04; C07D403/12; C07D405/04; C07D405/14; C07D409/04; C07D409/14; C07D413/14; C07D417/12; C07D417/14; C07D471/04; C07D487/04; C07D491/052; C07D498/04
Domestic Patent References:
| JP2010522238A | ||||
| JP2012512888A | ||||
| JP2009500338A | ||||
| JP2006512313A | ||||
| JP2011508750A | ||||
| JP2010524950A |
Foreign References:
| US20130096118 | ||||
| WO2003009852A1 |
Attorney, Agent or Firm:
Kawaguchi International Patent Office